Sildenafil Vs. Tadalafil for The Treatment of Benign Prostatic Hyperplasia: A Single-arm Self-controlled Clinical Trial
CONCLUSION: Considering the significantly better improvement of PVR and IPSS-Qol index with sildenafil, this drug can be nominated as a suitable alternative for tadalafil as a BPH treatment, especially in younger patients who don't have any contraindications.PMID:37245088 | DOI:10.22037/uj.v20i.7593
Source: Urology Journal - Category: Urology & Nephrology Authors: Mazyar Zahir Mohammad Samzadeh Amirhossien Poopak Ali Reza Khoshdel Arash Armin Source Type: research
More News: Benign Prostatic Hyperplasia | Cialis | Clinical Trials | Erectile Dysfunction | Urology & Nephrology | Viagra